Skip to content

Effect of perioperative transcutaneous electrical acupoint stimulation on postoperative fatigue syndrome in patients undergoing gynecologic laparoscopic surgery

Effect of perioperative transcutaneous electrical acupoint stimulation on postoperative fatigue syndrome in patients undergoing gynecologic laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000795
Enrollment
Unknown
Registered
2025-04-21
Start date
2025-04-28
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative fatigue syndrome

Interventions

TEAS group(group T):Patients received TEAS at bilateral Zusanli (ST36), Shangjuxu (ST37), Neiguan (PC6) and Hegu (LI4) starting 30 min pre-anesthesia, maintained through PACU stay with 2/10 Hz dense-
control group(group C):The control group underwent electrode placement without electrical stimulation.

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing first-time laparoscopic surgery in lithotomy position with an anticipated operative duration of less than 3 hours.; (2) Age 18-60 years old and BMI 18.5-27.9 kg/m²; (3) ASA Grade I-II ; (4) Able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with skin damage, infection, ulcers, or skin diseases at the acupoint stimulation site; (2) Patients allergic to electrode pads; (3) Patients with a history of acute or chronic infections, chronic pain, or autoimmune diseases; (4) Patients with cardiac pacemakers or other metal internal fixation devices; (5) Patients with severe dysfunction of vital organs (heart, liver, lungs, kidneys, brain, etc.) before the procedure; (6) Patients who have recently used sedative-hypnotic drugs, hormones, antiemetics, or immunosuppressants; (7) Patients with neurological or psychiatric disorders, impaired consciousness, or inability to communicate normally.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative fatigue syndrome;Postoperative fatigue level;

Secondary

MeasureTime frame
Incidence of postoperative dizziness;Incidence of chronic postoperative pelvic pain;Intraoperative urine output;Intraoperative propofol consumption;Incidence of non-incisional pain;Bruggrmann Comfort Score, BCS;Time to foley catheter removal postoperatively;Intraoperative remifentanil consumption;15-item quality of recovery score, QoR-15;Time to first postoperative liquid diet intake;Time to first postoperative water intake;State Anxiety Inventory Scale, S-AI;Incidence of postoperative constipation;Heart rate, HR;Athens insomnia scale, AIS;Intraoperative blood loss;Diastolic blood pressure, DBP;Time to first postoperative defecation;Time to first out-of-bed ambulation;Systolic blood pressure, SBP;Incidence of postoperative fever;Satisfaction score;Incidence of postoperative nausea and vomiting;Incidence of Postoperative abdominal distension;Rescue analgesia rate;First postoperative exhaust time;

Countries

China

Contacts

Public ContactJuan Li

The First Affiliated Hospital of University of Science and Technology of China

huamuzi1999@126.com0551-62284460

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026